<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Reviews &amp; Perspectives on Pharmacy AI Newsletter</title>
    <link>https://bishopbpharmd.github.io/Pharmacy-AI-Newsletter/tags/reviews--perspectives/</link>
    <description>Recent content in Reviews &amp; Perspectives on Pharmacy AI Newsletter</description>
    <generator>Hugo -- 0.151.0</generator>
    <language>en-us</language>
    <lastBuildDate>Sat, 04 Oct 2025 21:47:54 -0400</lastBuildDate>
    <atom:link href="https://bishopbpharmd.github.io/Pharmacy-AI-Newsletter/tags/reviews--perspectives/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>LLMs show partial utility for DDI checks</title>
      <link>https://bishopbpharmd.github.io/Pharmacy-AI-Newsletter/posts/ddi_abstract/</link>
      <pubDate>Sat, 04 Oct 2025 21:47:54 -0400</pubDate>
      <guid>https://bishopbpharmd.github.io/Pharmacy-AI-Newsletter/posts/ddi_abstract/</guid>
      <description>This review finds that LLMs can detect many common drug–drug interactions with clear explanations, but they miss uncommon ones, vary in severity ratings, and sometimes hallucinate contraindications.</description>
    </item>
    <item>
      <title>Rule-Based CDS: A Literature Review of Impact and Evolution</title>
      <link>https://bishopbpharmd.github.io/Pharmacy-AI-Newsletter/posts/ai_cds_abstract/</link>
      <pubDate>Sat, 04 Oct 2025 21:47:54 -0400</pubDate>
      <guid>https://bishopbpharmd.github.io/Pharmacy-AI-Newsletter/posts/ai_cds_abstract/</guid>
      <description>This scoping review of 28 studies (2007–2023) maps how rule-based CDSS are used across medicine, highlighting both measurable gains and persistent barriers.</description>
    </item>
  </channel>
</rss>
